文献速递糖尿病

注射器与针头重复使用对2型糖尿病患者临床结局的影响:一项12周随机临床试验

Impact of Syringe and Needle Reuse on the Clinical Outcomes of Patients With Type 2 Diabetes: A 12-Week Randomized Clinical Trial.
PubMed 文献 · Diabetes Care · 2024-01-01

本研究纳入71例既往至少重复使用3次注射器与针头的2型糖尿病成人患者,随机分为不重复使用组与重复使用5次组,评估12周内血糖控制、疼痛评分及皮肤并发症等结局。重复使用组脂肪增生/结节增加(0.16±0.08,P=0.040),但疼痛与血糖控制未恶化,皮肤并发症总数、生活质量及微生物污染无差异,两组治疗依从性均改善且重复使用组改善更大。

要点

  • 重复使用注射器与针头与脂肪增生/结节轻度增加相关(0.16±0.08,P=0.040)。
  • 重复使用未导致疼痛或血糖控制恶化,即使注射时用力较大。
  • 两组皮肤并发症总数、生活质量及微生物污染无差异,依从性均改善。

核心结论

  • 重复使用注射器与针头与脂肪增生/结节轻度增加相关,但对2型糖尿病患者血糖控制无短期影响。

研究设计与样本

  • 随机临床试验,纳入71例既往至少重复使用3次注射器与针头的2型糖尿病成人患者,随机分为不重复使用组与重复使用5次组,随访12周。
  • 参与者平均±标准差年龄59.7±8.8岁,59%为女性,糖尿病病程中位数18年(四分位距10-25年),平均BMI 31.7±6.7 kg/m2。

主要发现

  • 重复使用组脂肪增生/结节增加(0.16±0.08,P=0.040)。
  • 重复使用组疼痛或血糖控制未恶化,即使注射器与针头以很大力气插入皮肤时亦如此。
  • 两组皮肤并发症总数、生活质量或微生物污染无差异。
  • 两组治疗依从性均改善,重复使用组改善更大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the clinical and laboratory outcomes of patients with type 2 diabetes by comparing the no reuse or reuse of syringes and needles for insulin injection. RESEARCH DESIGN AND METHODS: Adults with type 2 diabetes who had reused syringes and needles at least three times were randomly instructed either to not reuse or to reuse insulin syringes and needles five times. The primary outcomes assessed were glycemic control, pain scores, and skin complications (ecchymosis, lipohypertrophy, nodules, infection) at baseline and 4, 8, and 12 weeks after the intervention. Secondary outcomes included treatment adherence, quality of life, microbiological contamination of syringes and needles, needle quality, and insulin injection technique. RESULTS: Among the 71 participants (mean ± SD age 59.7 ± 8.8 years), 59% were women with a median duration of diabetes of 18 years (interquartile range 10-25 years) and a mean BMI of 31.7 ± 6.7 kg/m2. The group that reused syringes and needles experienced an increase in lipohypertrophy/nodules (0.16 ± 0.08, P = 0.040) but did not experience worsening pain or glycemic control, even when the syringes and needles were inserted into the skin with great effort. There was no difference in the total number of skin complications, quality of life, or microbiological contamination. Both groups improved treatment adherence, with a greater increase in the reuse group. CONCLUSIONS: The reuse of syringes and needles is associated with a modest increase in lipohypertrophy/nodules but does not have a short-term impact on glycemic control in patients with type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Berlanda G, Telo GH, Gossenheimer AN, et al. Impact of Syringe and Needle Reuse on the Clinical Outcomes of Patients With Type 2 Diabetes: A 12-Week Randomized Clinical Trial. Diabetes Care. 2024. PMID: 39405489. doi:10.2337/dc24-0157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。